The most common surgical procedure involving removal of a portion of the pancreas is called a
pancreaticoduodenectomy. A
distal pancreatectomy is removal of the body and/or tail of the pancreas. It is considered the standard procedure for cancer lesions found in the body or tail of the pancreas. The surgery is considered safe, with low morbidity and mortality, with the exception of in the case of pancreatic adenocarcinomas, a type of cancer that has a poor
prognosis. A study by Du et. al. published in 2013 showed decreased intraoperative
hemorrhage and risk of post-operative diabetes, however, there was an increase in pancreatic fistula rate in patients that underwent a middle segmental pancreatectomy. Total removal of the pancreas can lead to an insufficiency of hormones produced. In total pancreatectomy, the
gallbladder, distal
stomach, a portion of the
small intestine, associated
lymph nodes and in certain cases the
spleen are removed in addition to the entire pancreas.
TP-IAT (total pancreatectomy with islet autotransplantation) has also gained respectable traction within the medical community. These procedures are used in the management of several conditions involving the pancreas, such as benign
pancreatic tumors,
pancreatic cancer, and
pancreatitis. TP-IAT is used to prevent post-operative diabetes and the subsequent complications. The islet cells are isolated from the explanted pancreas into the portal vein in order to help mitigate the loss of endocrine function following total pancreatectomy. ==Contraindications==